甲基转移酶
化学
酶
赖氨酸
表观遗传学
染色质
组蛋白
生物化学
乙酰化
甲基化
基质(水族馆)
细胞生物学
生物
氨基酸
DNA
基因
生态学
作者
Scott D. Cowen,Daniel John Russell,Leslie A. Dakin,Huawei Chen,Nicholas Larsen,Robert E. Godin,Scott R. Throner,Xiaolan Zheng,Audrey Molina,Jiaquan Wu,Tony Cheung,Tina D. Howard,Renee Garcia‐Arenas,Nicholas Keen,Christopher S Pendleton,Jennifer A. Pietenpol,Andrew D. Ferguson
标识
DOI:10.1021/acs.jmedchem.6b01303
摘要
Protein lysine methyltransferases (KMTs) have emerged as important regulators of epigenetic signaling. These enzymes catalyze the transfer of donor methyl groups from the cofactor S-adenosylmethionine to specific acceptor lysine residues on histones, leading to changes in chromatin structure and transcriptional regulation. These enzymes also methylate an array of nonhistone proteins, suggesting additional mechanisms by which they influence cellular physiology. SMYD2 is reported to be an oncogenic methyltransferase that represses the functional activity of the tumor suppressor proteins p53 and RB. HTS screening led to identification of five distinct substrate-competitive chemical series. Determination of liganded crystal structures of SMYD2 contributed significantly to "hit-to-lead" design efforts, culminating in the creation of potent and selective inhibitors that were used to understand the functional consequences of SMYD2 inhibition. Taken together, these results have broad implications for inhibitor design against KMTs and clearly demonstrate the potential for developing novel therapies against these enzymes.
科研通智能强力驱动
Strongly Powered by AbleSci AI